Louisiana tops Botox injections per capita in NavMDs study

NavMDs’ new state-by-state analysis finds Louisiana has the most Botox injectors per capita, while the South Atlantic accounts for 30% of the nation’s annual neuromodulator injections. The study also shows prices vary sharply by state and that Botox still dominates injector menus nationwide.

Why it matters: - Botox demand is concentrated in parts of the South and Northeast, which may affect where patients can find providers and what they pay. - The study shows a market that is growing fast, with national annual injections nearly doubling since 2019. - The data also suggests Botox remains the dominant brand in a competitive cosmetic injectables market.

What happened: - NavMDs released "Botox Nation," a state-by-state analysis of Botox usage, provider density and pricing across the United States. - Louisiana ranked first for Botox injectors per capita, with 0.83 listed injectors per 100,000 residents. - New York followed at 0.77 per 100,000 residents, and Washington, DC, posted 0.71. - The South Atlantic region delivered 3.01 million neuromodulator injections a year, equal to 30% of the national total. - The South Atlantic reached that share with 20.5% of the U.S. population, or 2.3 times the Midwest's injection rate.

The details: - The national median Botox session price was $440. - Massachusetts had the highest reported median price at $600 per session. - North Carolina had the lowest reported median price among the states cited, at $260 per session. - National annual volume rose from 5.04 million injections in 2019 to 9.88 million, according to the American Society of Plastic Surgeons. - Patients ages 40 to 54 received 57% of those injections. - Botox appeared on 88% of injector menus. - Dysport appeared on 14% of injector menus. - Xeomin appeared on 3.6% of injector menus. - Jeuveau appeared on 1.2% of injector menus. - Daxxify appeared on 0.5% of injector menus. - The analysis used American Society of Plastic Surgeons' 2024 Procedural Statistics Release, NavMDs' directory data on 1,513 listed neuromodulator injectors and 743 published session prices, and U.S. Census Bureau 2024 population estimates. - The full analysis includes an interactive state map, a top-10 provider table and per-state pricing. - More information is available in the full study.

Between the lines: - The regional concentration suggests aesthetic medicine demand is not evenly distributed across the country. - The pricing gap shows patients can face very different out-of-pocket costs depending on location. - Botox's menu dominance indicates competitors have not yet broken its lead in many practices. - The provider directory's price and inventory data point to growing consumer interest in transparency around cosmetic procedures.

What's next: - NavMDs is positioning its directory data as a way for patients to compare providers, credentials, ratings and listed prices. - The state map and provider tables could help steer patients toward lower-cost markets or denser provider areas. - Future updates may show whether rising demand and brand competition change state rankings or pricing gaps.

The bottom line: - Botox use is surging, but access, price and provider density still vary sharply by state and region.